Andrew Feigin, MD

Director, Laboratory of Experimental Therapeutics for Movement Disorders
The Feinstein Institute for Medical Research

Director, Huntington’s Disease Society of America Center of Excellence
North Shore University Hospital

Professor, Neurology and Molecular Medicine
Hofstra North Shore-LIJ School of Medicine

 

 


Recent Posts By: Andrew Feigin, MD

Alive and Well with Huntington’s Disease

Spend next Wednesday evening with patients, researchers and clinicians who collaborate to understand Huntington’s disease. Patients with this genetic neural disorder struggle with muscle coordination plus their attention span, memory, reasoning, problem solving, decision making, language, learning and/or emotions. On April 16 at 5 p.m., one of my patients and her daughter will share their… posted in: Event, Movement Disorders, Neuro, Researchtags:


Gene Therapy: A New Possibility
for Parkinson’s Patients

A new gene therapy called ProSavin may help reduce motor symptoms of Parkinson’s disease, suggests a recent study published in The Lancet. Although Parkinson’s cannot be cured, medications can improve symptoms. Typically, treatment includes dopamine-replacement therapy to replenish the main brain chemical that patients with Parkinson’s lose. This new gene therapy restores the patient’s dopamine… posted in: Neuro, Newstags:


Weight Training May Improve Parkinson’s Symptoms

Weight training may improve the motor symptoms of Parkinson’s disease, according to a new study that will be presented at the American Academy of Neurology’s 64th Annual Meeting in New Orleans this coming April. In the study, 48 people with Parkinson’s disease used progressive resistance exercise (weight training) or fitness counts, which included flexibility, balance… Read more »